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A quantitative nucleosome occupancy assay re-
vealed rules for nucleosome disposition in yeast
and showed how disposition affects regulation of
the GAL genes. Here, we show how those findings
apply to the control of Kit, a mammalian gene. The
Kit promoter lies in a CpG island, and its enhancer
(active in mast cells) lies some 150 kb upstream.
Nucleosomes form with especially high avidities at
theKitpromoter, a reaction that, we surmise, ensures
extremely low basal expression. In mast cells, tran-
scriptional activators displace nucleosomes that
are less tightly formed at the Kit enhancer. In turn,
the active enhancer replaces a single Kit promoter
nucleosome with the transcriptional machinery,
thereby inducing transcription over 1,000-fold. As at
the yeastGAL genes, the inhibitory effects of nucleo-
somes facilitate high factors of induction bymamma-
lian activators working in the absence of specific
repressors.INTRODUCTION
How does the wrapping of DNA in nucleosomes, a pervasive
feature of eukaryotes, affect gene regulation? In bacteria, acti-
vators recruit RNA polymerase (Pol) to specific promoters in a
simple binding reaction. Absent the activator, unless a repressor
intervenes, the spontaneous (basal) rate of transcription is signif-
icant. Most bacterial activators are paired with specific repres-
sors that can exclude binding of RNA Pol to promoters in the
absence of the activator, and the resulting difference between
the repressed and activated states can be very high—at least
1,000-fold in the case of the lac genes. Eukaryotic activators
also work by recruitment (Ptashne and Gann, 2002). But high
levels of induction can be achieved in eukaryotes by activators
working in the absence of paired repressors (Struhl, 1999). It
has long been surmised that nucleosome formation replaces
the role of specific repressors in eukaryotes, and in several in-
stances, in eukaryotes as well as in yeast, promoter nucleosome
removal is an early step in gene activation (see e.g., Agalioti et al.,
2000; Becker and Ho¨rz, 2002; Bryant et al., 2008; Cairns, 2009).
Do nucleosomes efficiently suppress basal transcription, and ifso, how might they do so without blocking activator access to
the DNA of regulatory proteins?
As assayed in vitro, DNA sequences differ in their nucleo-
some-forming potentials, that is, the relative avidities with which
they form nucleosomes. Absent other influences, these differ-
ences should be reflected in the nucleosome occupancies
of different sequences in vivo. To measure such occupancies,
we developed a ‘‘quantitative nucleosome occupancy’’ assay,
a modification of the classical MNase-protection assay. In our
assay, crosslinked chromatin is digested with the nuclease at a
series of concentrations spanning a 10,000-fold range. Sixty-
base pair DNA fragments (amplicons) remaining after a fixed
time are then assayed by quantitative PCR (qPCR). If, for
example, a given amplicon were wrapped in a nucleosome in
50% of the cells at the moment of crosslinking, a biphasic diges-
tion curve would be generated, one part of which corresponds to
naked DNA, the other to protected DNA. By noting the inflection
point of the curve (50% in this example), we determine the frac-
tion of the corresponding DNA in the population that is free and
the fraction covered (protected) by a nucleosome. The latter
fraction is the nucleosome occupancy at the moment of cross-
linking (see Figure S1). By analyzing overlapping fragments, we
determine where on DNA nucleosomes are formed, i.e., nucleo-
some positioning. Becausewe examine inflection points, and not
absolute rates of digestion, differences in MNase sensitivity of
different DNA sequences are not relevant. Additional experi-
ments confirm that in yeast, protected regions ranging in size
from about 130 bp (in one case) to about 160 bp (the typical
case) reflect the presence of nucleosomes.
As applied to the yeast GAL genes (Bryant et al., 2008; Floer
et al., 2010; Wang et al., 2011), our assay revealed several find-
ings. Most of the amplicons corresponding one or another part
of the genome yielded biphasic curves such as the two middle
curves shown in Figure S1. A typical nucleosome in an open
reading frame (e.g., that of the GAL1 gene) occupies DNA to a
level of about 50%–70%, whereas a nucleosome at AT-rich
promoter sequences occupies DNA less efficiently—about
30%–50%. Nucleosomes found in the GALl1/GALl10 promoters
are rather precisely positioned (phased). Such nucleosomes
protect sharply defined peaks of DNA that are separated by
short (ca. 10 bp) valleys of sensitive DNA. This nucleosome
positioning is not determined by DNA sequence per se but
rather by a barrier to nucleosome movement/formation.
The regulatory element called the UASg (upstream-activating
sequence galactose), which lies between the two promoters,Cell Reports 4, 445–453, August 15, 2013 ª2013 The Authors 445
comprises such a barrier in wild-type (WT) cells (see the
following). GAL4 itself can bind DNA in chromatin in two
different scenarios. In WT cells, a pre-existing protein-DNA
complex (which comprises the UASg barrier alluded to above)
displays the GAL4 sites for ready access. When the complex
is dismantled by mutation, GAL4 must compete with and
displace nucleosomes. In this mutant case, GAL4 binding to
DNA, although slower than in the WT case, proceeds to near
completion. This second scenario also applies to cases in which
GAL4 is used to activate genes in cells of higher eukaryotes, in
which the facilitating complex is not formed. We suspect that
the fact that there are several closely spaced GAL4 sites
ensures a cooperative effect of GAL4 competition with nucleo-
somes for DNA. Among seven variants at the site of a phased
promoter nucleosome, because the GC content was increased
from 25% to 56% (with AT dinucleotides interspersed modulo
10 bp), nucleosome avidity (occupancy) increased, but the
position of the phased nucleosome did not change. Upon
gene induction, the activator (GAL4 in our case) recruits the
‘‘nucleosome remodeler’’ SWI/SNF, which in turn removes the
promoter nucleosomes, a necessary step for gene activation.
Promoter nucleosomes form tightly enough such that basal
expression is effectively eliminated, and energy in the form of
ATP (utilized by SWI/SNF) is required for promoter clearance.
How might these findings from yeast experiments apply to
regulation of a mammalian gene? In yeast, activators must be
positioned within about 200 bp of the promoter to work effec-
tively. In contrast, activators bound at mammalian enhancers
can work when positioned many thousands of base pairs
away from the promoter. DNA methylation, which could affect
transcription of mammalian genes, is absent from yeast. Unlike
their counterparts in yeast, mammalian promoters are often
found in DNA regions of very high GC content. We explore these
factors because they may apply to the regulation of the murine
Kit gene. A useful control for some experiments is provided by
the Myog gene.
The murine Kit gene, which encodes a receptor tyrosine
kinase, is transcribed in an array of cell types during develop-
ment and in postnatal animals, and aberrantly in several cancers
(Piao et al., 1996; Nishida et al., 1998; Smalley et al., 2009; Nick
et al., 2012). Kit transcription is abolished in otherwise normal
mast cells by deletion of a 7 kb fragment located some 150 kb
upstream (Berrozpe et al., 2006). That deletion has no effect on
Kit expression in other cells where, presumably, Kit expression
is driven by other enhancers. An inversion mutation (called
WSH) has moved the 7 kb mast enhancer some 2 cM further
upstream, and expression in mast cells is greatly decreased.
The Kit promoter, like many other mammalian promoters, lies
in a CpG island. As implied, it is rich in overall GC content as
well as being rich in CpG dinucleotides, potential targets for
DNA methylation. In contrast, the Myog promoter, although
also GC rich, is relatively sparse in CpG dinucleotides. CpG
dinucleotides in CpG islands are typically undermethylated
compared with their counterparts elsewhere in the genome
(Deaton and Bird, 2011). Neither Kit nor Myog is transcribed in
myeloid cells, and Myog is also silent in mast cells.
A recent model predicts that nucleosome avidities of different
DNA sequences are accurately predicted simply by relative GC446 Cell Reports 4, 445–453, August 15, 2013 ª2013 The Authorscontent (Tillo and Hughes, 2009; Hughes and Rando, 2009). In
contrast, a previous model had predicted that interspersed
(modulo 10 bp) AT dinucleotides were required for high nucleo-
some avidity (Segal et al., 2006). That requirement was some-
what less prominent in a subsequent model (Segal and Widom,
2009). There are conflicting reports as to whether GC-rich
mammalian promoters are highly occupied by nucleosomes:
Ramirez-Carrozzi et al. (2009) claim that at least certain CpG
island promoters are depleted of stable nucleosomes; Tillo
et al. (2010) claim that most mammalian regulatory sequences
(including promoters and enhancers) are covered with nucleo-
somes that form with high avidity; and Valouev et al. (2011)
claim that in a subset of eukaryotic promoters, nucleosome
density is lower than in others. The latter authors do not
comment on the relative nucleosome avidities of CpG islands
and more typical DNA, but they do suggest that where such
islands are depleted for nucleosomes, that depletion is corre-
lated with gene activity.
Here, we examine three states of expression of the murine Kit
gene: strongly expressed (in mast cells), off (in myeloid cells),
and weakly on (in mast cells bearing the WSH allele in which
the enhancer has been moved very far upstream). The Myog
gene, off in both mast and myeloid cells, provides another useful
comparison. Among other findings, we show that nucleosomes
form with significantly higher avidities at the Kit and Myog
promoters than at the Kit enhancer. These features, we suggest,
facilitate binding of activator proteins to the enhancer while
virtually excluding the basal transcriptional machinery from
the promoter. When at its ordinary position (i.e., at 150 kb
upstream), in a process evidently facilitated by DNA looping,
the enhancer-bound proteins replace a single nucleosome at
the promoter with the transcriptional machinery, thereby acti-
vating transcription over 1,000-fold.
RESULTS
The Murine Kit Gene
Figure 1A shows a schematic of the KitWT and WSH alleles and
their relative expression levels in mast and myeloid cells. The Kit
gene is induced in mast cells over 1,000-fold as judged from a
comparison with transcription levels in myeloid cells—the latter
is, in fact, so low as to be near the limit of detection by qPCR.
Mast cells bearing the WSH allele express a level of Kit mRNA
that is slightly higher than that observed for Kit in myeloid cells
butmuch lower than that forWTKit in mast cells. Table S1 shows
the levels of expression of the Kit andMyog genes in the two cell
types used here.
Nucleosomes at the Kit Locus
In myeloid cells (in which the gene is silent), nucleosomes are
distributed along the entire length of the enhancer with an
average occupancy of about 55%. In striking contrast, the
promoter is occupied to near 100% by nucleosomes in these
cells (Figure 1B).
The Kit Enhancer
In mast cells, the enhancer appears essentially as in myeloid
cells in our nucleosome assay, except that two approximately
Figure 1. The Murine Kit Locus and Nucleosome Occupancies at the Kit Enhancer and Promoter
(A) In aWTKit allele, theKit enhancer active inmast cells is positioned some 150 kb upstream from theKitATG. In theWSHmutant, a large chromosomal inversion
has moved this enhancer far upstream. The break point of the inversion is 72 kb upstream of the ATG. The relative levels of Kit mRNA are shown to the right.
(B and C) Each green bar describes the nucleosome occupancy of an approximately 60 bp amplicon. (B) The enhancer (Enh) and promoter regions as found in
myeloid cells are illustrated. (C) The enhancer as found inmast cells is shown. Two regions (500–300 bp each) in the active enhancer are depleted of nucleosomes,
as designated by A and B, and also by the red lines.300–500 bp segments (labeled A and B) are depleted of nucleo-
somes. These regions are centered around positions 151.2 kb
(in fragment A) and147.7 kb (fragment B) upstream of the tran-
scription start site (measured for the enhancer at its WT position)
(Figure 1C).
Chromatin immunoprecipitation (ChIP) analyses reveal that in
mast but not in myeloid cells, the proteins Gata2 and Gata1 are
bound to the enhancer. These peaks appear identically whether
the enhancer is at its WT position or is moved far upstream by
the WSH inversion (Figure 2A). The peak of Gata2 overlaps the
trough of nucleosome depletion in enhancer segment A, and
the peak of Gata1 similarly overlaps the corresponding trough
of nucleosome depletion in segment B (Figure 2B). Putative
Gata1 and Gata2 motifs, marked above the lines in Figure 2A,
are scattered throughout the enhancer as revealed by MatIns-pector software sequence analysis (Quandt et al., 1995). The
fact that most of the Gata1 and Gata2 sites are ignored suggests
that these GATA proteins bind cooperatively with other proteins
to the positions indicated.
Nucleosomes bearing the modifications H3K27ac and
H3K4me1 flank the area of nucleosome depletion in segment A
of the Kit enhancer in mast cells (Figures 3A and 3B). The modi-
fied nucleosomes are found identically whether the enhancer is
part of the WT or the WSH Kit allele. No such modified histones
are found associated with the enhancer in the myeloid cells
(Figures 3A and 3B). The distribution of these marks is similar
in segment B (data not shown).
The ENCODE database on the UCSC genome browser
website shows analyses of the Kit locus as found in 15 different
murine tissues and cell lines, none of which corresponds toCell Reports 4, 445–453, August 15, 2013 ª2013 The Authors 447
Figure 2. Nucleosome and GATA at the Kit Enhancer
(A) ChIP analysis of Gata2 andGata1 bound along the 7 kb enhancer inmast cells. The peak of Gata2 is centered on position151.2 in enhancer segment A, and a
separate peak of Gata1 is centered on position147.7 in fragment B. Gata2 and Gata1 sites revealed by DNA sequence analysis are shown in the lines above the
peaks. Results of three separate measurements are shown: orange indicates WT Kit in mast cells, blue shows the WSH Kit mutant in mast cells, and green
presents WT Kit in myeloid cells.
(B) Nucleosome occupancies over ca. 800 bp DNA segments centered on position 151.kb in segment A and 147.7 kb in segment B are shown. The three
curves are color coded as in (A).mast cells. In no case is there evidence of nucleosome clear-
ance or histone modifications at or near the enhancer
described here. In some cases, the presence of RNA Pol and
certain histone modifications at the promoter indicated pro-
moter activity. We presume that in those cases, transcrip-
tion was driven by enhancers other than the one we have
described here.448 Cell Reports 4, 445–453, August 15, 2013 ª2013 The AuthorsPromoter
In myeloid cells (in which the Kit gene is off), and in mast cells
bearing the WSH mutant locus (in which the gene is barely on),
nucleosomes occupy the Kit promoter with unusually high
avidities: 80%–100% (Figures 1B and 4A). Similar high nucleo-
some occupancy is seen at the promoter of the unrelated
Myog gene (Figure S2). The high GC contents of the Myog and
Figure 3. Histone Acetylation and Methyl-
ation at the Kit Enhancer Fragment A
Positions of histones bearing the marks H3K27ac
(A) and H3K4me1 (B) were determined by high-
resolution ChIP analyses. The color coding of the
curves is as in Figure 2. The position of the peak of
Gata2 is also indicated.Kit promoters are shown in Table S2. We have never seen such
high occupancies for normal nucleosomes in yeast, consistent
with the fact that yeast DNA does not contain regions as GC
rich—and hence, as favorable for nucleosome formation—as is
found in these promoters (see Discussion).
Other salient findings concerning the Kit and Myog pro-
moters include the following. In mast cells bearing the WT Kit
allele, a single nucleosome that would otherwise cover the
transcription start site is missing (Figure 4A). ChIP analyses
showing the distribution of the histone modification H3K4me3
similarly reveal that a nucleosome is missing from the active
Kit promoter (Figure 4B). And a similar analysis probing for
Pol II reveals the presence of that enzyme and other compo-
nents of the transcriptional machinery at the transcription start
site (Figure 4C). In Figures 4A, 4B, and S3, the nucleosomes
just upstream of the recruited transcriptional machinery
(marked by the absence of a nucleosome and the presence
of Pol II) are particularly well positioned (phased), an effect
seen most clearly in the nucleosome occupancy assay of Fig-
ure 4A. In all cases where Pol II is not detected at the promoter
(either Kit or Myog), nucleosomes form avidly, but phasing is
less evident. The result reinforces the notion that occupancy
and phasing are not necessarily linked and that the transcrip-
tional machinery comprises a barrier that can phase nucleo-
somes. Promoter nucleosomes remaining at the activated KitCell Reports 4, 445–45promoter (Figure 4A) form with high
avidity, suggesting that the H3K4me3
modification per se does not affect
nucleosome formation.
Cohesin
Several recent studies have shown that
promoter-enhancer communication can
be facilitated by the protein cohesin,
and the presence of cohesin at both
elements has been taken as a sign of
looping (Kagey et al., 2010; Majumder
and Boss, 2011; Liu et al., 2011; Dorsett
2011; Taberlay et al., 2011; Guo et al.,
2012). Figure 5 shows that, as assayed
by ChIP, cohesin is bound to both the
Kit enhancer and promoter in mast cells
bearing the WT Kit allele, suggesting
that Kit enhancer-promoter communica-
tion is accommodated by DNA looping.
In myeloid cells, there is no such signal,
and in WSH cells, the signal is found at
the enhancer, but not at the promoter.
The latter result implies that cohesincan load on the enhancer independently of loading at the
promoter.
DNA Methylation
The Kit promoter is highly methylated in myeloid cells but is
unmethylated (for both the WT and WSH alleles) in mast cells.
Nucleosomes form with equal avidities in the three cases (with
one nucleosome having been removed from the WT allele in
mast cells). Thus, DNA methylation has no obvious effect on
nucleosome formation. The Myog promoter is, in contrast, only
lightly methylated in both mast and myeloid cells. There are
fewer CpG residues here (Table S2), and each such element is
methylated only sporadically (Figure S4). Nucleosomes form
with high avidities at this promoter in both cell types (Figure S2),
and basal transcription is virtually undetectable (Table S1). Thus,
inhibition of basal transcription correlates with high nucleosome
avidities and not with DNA methylation.
DISCUSSION
Proteins bound to the Kit enhancer activate Kit transcription
over 1,000-fold in mast cells. This activation is observed with
the enhancer located at its WT position, i.e., 150 kb upstream
of the promoter. When displaced many megabases further up-
stream, the enhancer has little or no stimulatory effect. Activation3, August 15, 2013 ª2013 The Authors 449
Figure 4. Nucleosomes and Pol II at
Promoters
(A) Nucleosomes at the Kit promoter as deter-
mined by the nucleosome occupancy assay are
shown.
(B) H3K4me3 as determined by high-resolution
ChIP analyses is shown.
(C) Pol II as determined by ChIP analysis is
presented.
The curves are color coded as in Figures 2 and 3.is correlated with the removal of a single promoter nucleosome
and its replacement by the transcriptional machinery. This ‘‘ac-
tion at a distance’’ evidently involves DNA looping as evidenced
by the presence of cohesin at promoter and enhancer in the acti-
vate state. The high factor of induction of the Kit gene, similar to
that of the GAL genes in yeast, requires that the basal level of
expression be extremely low. In themammalian cases discussed
here, as in yeast, we surmise that promoter nucleosomes ensure
low basal expression by blocking spontaneous binding of the
transcriptional machinery. Even the more weakly forming nucle-
osomes at the yeast promoters require energy in the form of ATP
(utilized by SWI/SNF) for their efficient removal upon induction
(Becker and Ho¨rz, 2002; Bryant et al., 2008), and we imagine450 Cell Reports 4, 445–453, August 15, 2013 ª2013 The Authorsthat induction of the Kit gene (as for the
IFN-b gene; Agalioti et al., 2000) similarly
requires energy-utilizing SWI/SNF.
Promoter
The Kit promoter, which lies in a CpG
island, forms nucleosomes with sig-
nificantly higher avidity than does its
enhancer, which lies in a region of more
typical GC content. This difference, we
suggest, facilitates activator binding to
the enhancer (with nucleosome displace-
ment) while efficiently blocking access
to the promoter in the uninduced state.
The Myog promoter, also GC rich, also
forms nucleosomes with high avidity,
but neither it nor the Kit promoter con-
tains significant numbers of interspersed
AT residues (see Figure S5), indicating
that such residues are unnecessary for
high nucleosome avidity.
The Kit promoter is heavily methylated
in myeloid cells, but not in mast cells.
The Myog promoter contains few CpG
residues, and those residues are methyl-
ated only sporadically in myeloid and
mast cells, in both of which the promoter
is silent. The common feature of the
two silent promoters is thus the high
avidity with which they form nucleo-
somes. Moreover, a comparison of the
hypomethylated Kit promoter (as found
in mast cells) with its hypermethylatedform (in myeloid cells) indicates that DNA methylation has no
obvious effect on nucleosome avidity.
Kit promoter nucleosomes, though formed with high avidities,
are not phased in the uninduced state but, rather, form more
irregularly over the region. Upon induction, the nucleosomes
remaining become phased, a feature we attribute to the pres-
ence of the transcriptional machinery acting as a barrier.
Thus, in mammalian cells as in yeast, phasing is determined
not by the nucleosome-forming potential of any given sequence
but rather by barriers to nucleosome formation and/or move-
ment. It has been reported that at other active mammalian
promoters, the DNA-bound transcriptional machinery was sur-
rounded by phased nucleosomes (Schones et al., 2008). The
Figure 5. Cohesin at Enhancer and
Promoter
(A–C) Detection of cohesin by ChIP analyses at
three positions in the Kit locus is shown: (A) Kit
promoter, (B) enhancer segment A, and (C)
enhancer segment B. The color coding of the
curves is as in Figures 2, 3, and 4.phased nucleosomes remaining at the active Kit promoter bear
the modification H3K4me3. We can say nothing about the func-
tion of the modification other than that it does not suffice for
nucleosome removal. A recent study in Drosophila failed to
detect any significant defect in transcriptional regulation in
mutant Drosophila in which all H3K4 methylation, including
H3K4me1, H3K4me2, and H3K4me3, had been eliminated
(Ho¨dl and Basler, 2012).
Our results are consistent with those of Valouev et al. (2011),
who noted that a subset of CpG island promoters was relatively
depleted of nucleosomes compared with other such promoters,
and they correlated this depletionwith gene activity.We suggest,
similarly, that in the other cases mentioned in the Introduction in
which nucleosome depletion was observed for supposedly inac-
tive genes that, in fact, were being transcribed at a low level.
Consistent with that view, Ramirez-Carrozzi et al. (2009) report
that prior to full induction, the primary response genes they
studied had already acquired histone modifications associated
with gene transcription.
Enhancer
Multiple proteins, including Gata2 and Gata1, fill, presumably
cooperatively, each of two ca. 300–500 bp segments of theCell Reports 4, 445–453Kit enhancer in mast cells. That reaction
occurs identically whether the enhancer
is close enough to the Kit promoter to
activate the gene (i.e., 150 kb upstream)
or moved so far upstream that it has little
if any effect. We do not detect any
obvious structure, such as that found
at the WT GAL4-binding sites in yeast,
that would facilitate activator binding to
the Kit enhancer. We surmise that if
any of these factors binds directly to a
nucleosome (Sekiya et al., 2009; Zaret
and Carroll, 2011), those nucleosomes
must be subsequently removed. The
two regions in the Kit enhancer at
which mast cell regulatory proteins
have replaced nucleosomes are flanked
by nucleosomes bearing the modifica-
tions H3K27ac and H3K4me1. We do
not know the function if any of these
marks, but their disposition illustrates
how modified nucleosomes can be
associated with active enhancers (Roh
et al., 2006; Heintzman et al., 2007,
2009; Barski et al., 2007; Cui et al.,
2009; Ernst et al., 2011; McManuset al., 2011). These nucleosomes form with avidities indistin-
guishable from those with which unmodified nucleosomes
form in the region.
Epigenetic Switches
The idea that the ground state of gene expression—i.e., that
occurring in the absence of an activator—is very low in eukary-
otes but not in bacteria has implications for gene regulatory pro-
cesses that underlie development. Phage lambda’s epigenetic
switch, for example, illustrates two requirements for maintaining
a stable ‘‘differentiated’’ state: specific activation (in this case, in
a positive feedback loop that maintains expression of a gene
required for lysogeny); and specific repression (of lytic genes).
Were the ground state of expression efficiently off, this require-
ment for a specific repressor would be obviated. In the scenario
we have described for the Kit and Myog genes, inhibiting or
removing the relevant activators would suffice to have this effect.
Put another way, nature shows us two ways to create a large
difference between the fully on and off states of gene expression:
use competing binding reactions, involving no ATP (as in most
bacterial cases); or use just an activator that selectively removes
one or more nucleosomes in an enzymatic step affected by a
recruited enzyme that uses ATP., August 15, 2013 ª2013 The Authors 451
EXPERIMENTAL PROCEDURES
Cell Culture
Bone marrow mast cells (BMMCs) were obtained by flushing the femurs and
tibias from adult mice with PBS. Mast cells and 32D myeloid cells were grown
in RPMI 1640 supplementedwith 10% fetal calf serum (FCS), 10% conditioned
medium from X63 interleukin (IL)-3-producing cells, nonessential amino acids,
and sodium pyruvate. The cells provided for these experiments were provided
by the Besmer Lab at MSKCC with IACUC oversight.
MNase-Protection Experiments
MNase-protection experiments of mast cell and myeloid cell chromatin were
performed essentially as described (Bryant et al., 2008). A total of 20 million
cells were resuspended in 500 ml of FA lysis buffer without EDTA. The resus-
pended cells were sonicated three times for 10 s using a Branson Sonifier
250 equipped with a microtip with the output set at 4. After centrifugation,
the supernatant was distributed in 24 separated tubes. FA lysis buffer contain-
ing protease inhibitors was added to a final volume of 200 ml. Micrococcal
nuclease solution in FA was added at a range of concentrations from 60 to
0.0000381 U in a 2-fold dilution series. The reaction was started by adding
5.6 ml of 10 mM CaCl2 to each tube. The reactions were incubated for 1.5 hr
at 37C. The DNA was purified using the QIAquick 96 PCR Purification Kit
(QIAGEN). The exact sequences of the primers used can be given upon
request.
ChIP Experiments
ChIP experiments were performed according to a protocol provided by
Upstate Biotechnology. For ChIP with BMMC and 32D cells, 107 cells were
used per immunoprecipitation. Briefly, the cells were crosslinked with 1%
formaldehyde, collected, andwashedwith PBS containing protease inhibitors.
The cells were resuspended in 400 ml SDS lysis buffer on ice for 10 min and
then sonicated with eight sets of 12 s pulses by a Branson Sonifier 250 cell.
Antibody against Gata1 and Rad 21 were purchased from Abcam. Antibodies
against Gata2 and RNA Pol II were obtained from Santa Cruz Biotechnology.
DNAs were phenol-chloroform extracted and ethanol precipitated. The immu-
noprecipitated DNAwas analyzed by qPCR as described (Bryant and Ptashne,
2003; Bryant et al., 2008). The exact sequences of the primers used can be
given upon request.
High-Resolution ChIP Experiments
ChIP experiments probing for H2B, H3K27ac, H3K4me, and H3K4me3 were
performed essentially as described by Floer et al. (2010). The crosslinked
DNA was digested with limiting amounts of MNase prior to immunoprecipita-
tion. The immunoprecipitated DNA was analyzed by qPCR as described
(Bryant and Ptashne, 2003; Bryant et al., 2008). Antibodies against H2B,
H3K27ac, H3K4me, and H3K4me3, were purchased from Abcam. The exact
sequences of the primers used can be given upon request.
DNA Methylation
Genomic DNA was treated with bisulfite using the EZ DNA Methylation-Direct
Kit from ZYMO Research. The experiments were performed according to a
protocol provided by ZYMO Research. After the treatment, the DNA was sub-
jected to 35 cycles of PCR. The PCR products were cloned using the TOPO TA
Cloning Kit according to a protocol provided by Invitrogen. We analyzed the
different clones by sequencing.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and two tables and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2013.07.001.
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